Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families

Blood

Volumn 92, Issue 7, 1998, Pages 2353-2358

  Martinelli, Ida ^a   Mannucci, Pier Mannuccio ^b   De Stefano, Valerio ^b   Taioli, Emanuela ^b   Rossi, Valentina ^b   Crosti, Francesca ^b   Paciaroni, Katia ^b   Leone, Giuseppe ^b   Faioni, Elena M ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; THROMBOPHILIA; THROMBOSIS;

EID: 0032190251     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2353.2353_2353_2358     Document Type: Article

References (37)

1. De Stefano V, Finazzi G, Mannucci PM: Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 87:3531, 1996
2. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
3. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503, 1993
4. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thromboembolism in apparently healthy men. N Engl J Med 332:912, 1995
5. Allaart CF, Briët E: Familial venous thrombophilia, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis (ed 3, vol 2). New York, NY, Churchill Livingstone, 1994, p 1349
6. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U: Inherited thrombophilia: part 1. Thromb Haemost 76:651, 1996
7. Engesser L, Broekmans A, Briët E, Brommer E, Bertina RM: Hereditary protein S deficiency: Clinical manifestation. Ann Intern Med 106:677, 1987
8. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73:712, 1989
9. Demers C, Ginsberg JF, Hirsh J, Henderson P, Blajchman MA: Thrombosis in atithrombin III deficient persons. Report of a large kindred and literature review. Ann Intern Med 116:754, 1992
10. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E: Increased risk of venous thrombosis in carriers of protein C deficiency defect. Lancet 341:134, 1993
11. Koster T, Rosendaal FR, Briët E, van der Meer J, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP: Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden thrombophilia study). Blood 85:2756, 1995
12. Heijboer H, Brandjes DP, Buller HR, Sturk A, ten Cate JW: Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323:1512, 1990
13. Tait RC, Walker ID, Perry DJ, Carrell RW, Islam SIA, McCall F, Mitchell R, Davidson JF: Prevalence of antithrombin III deficiency subtypes in 4000 healthy blood donors. Thromb Haemost 65:839, 1991
14. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503, 1993
15. Pabinger I, Schneider B, for the GTH Study Group on Natural Inhibitors: Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative retrospective study. Arterioscler Thromb Vasc Biol 16:742, 1996
16. Frezzato M, Tosetto A, Rodeghiero F: Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 143:1257, 1996
17. Taioli E, Martinelli I, Rossi V, Crosti F, Mannucci PM: Re: Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 147:605, 1998 (letter)
18. Sas G, Pepper DS, Cash JD: Plasma and serum antithrombin III: Differentiation by crossed immunoelectrophoresis. Thromb Res 6:87, 1975
19. Comp PC, Doray D, Patton D, Esmon CT: An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 67:504, 1986
20. Bertina RM, Koeleman RFC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
21. SAS Software. Cary, NC, SAS Institute. Inc, 1990
22. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504, 1995
23. Finazzi G, Caccia R, Barbui T: Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: Review of 404 cases. Thromb Haemost 58:1094, 1987
24. R506Q. J Biol Chem 270:4053, 1995
25. 506-factor V. Blood 85:3405, 1995
26. Lensen RPM, Rosendaal FR, Koster T, Allaart CF, de Ronde H, Vandenbroucke JP, Reitsma PH, Beitina RM: Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood 88:4205, 1996
27. Leroy-Matheron C, Levent M, Pignon JM, Mendonca C, Gouault- Heilmann M: The 1691 G→A mutation in the factor V gene: Relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemost 75:4, 1996
28. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR. Seligsohn U: Inherited thrombophilia: Part 2. Thromb Haemost 76:824, 1996
29. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Factor V Leiden: An additional risk factor for thrombosis in protein C deficient families. Blood 84:1031, 1994
30. Zöller B, Bernstdotter A, Garcia de Frutos P, Dahlbäck B: Resistance to activated protein C as an additional genetic risk factor for thrombosis in hereditary deficiency of protein S. Blood 85:3518, 1995
31. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM: Factor V Leiden: An additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 74:580, 1995
32. van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA: Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 75:417, 1996
33. Martinelli I, Magatelli R, Cattaneo M, Mannucci PM: Prevalence of mutant factor V in Italian patients with hereditary deficiencies of antithrombin, protein C or protein S. Thromb Haemost 75:694, 1996 (letter)
34. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S, on behalf of the ISCOAT Study Group: Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective, collaborative study (ISCOAT). Lancet 348:423, 1996
35. Rosendaal FR, Heijboer H, Briët E, Büller HR, Brandjes DPM, De Bruin K, Hommes DW, Vandenbroucke JP: Mortality in inherited antithrombin III deficiency - 1830 to 1989. Lancet 337:260, 1991
36. Allart CF, Rosendaal FR, Noteboom WMP, Briët E: No excess mortality in heterozygotes for hereditary protein C deficiency type I - 1820 to 1993. Thromb Haemost 73:1252, 1995
37. Hille ETM. Westerndorp RGJ, Vandenbroucke JP, Rosendaal FR: Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood 89:1963, 1997